These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
308 related articles for article (PubMed ID: 6283063)
1. Positive inotropic effect of amrinone in relation to cyclic nucleotide metabolism in the canine ventricular muscle. Endoh M; Yamashita S; Taira N J Pharmacol Exp Ther; 1982 Jun; 221(3):775-83. PubMed ID: 6283063 [TBL] [Abstract][Full Text] [Related]
2. Effects of new inotropic agents on cyclic nucleotide metabolism and calcium transients in canine ventricular muscle. Endoh M; Yanagisawa T; Taira N; Blinks JR Circulation; 1986 Mar; 73(3 Pt 2):III117-33. PubMed ID: 2417745 [TBL] [Abstract][Full Text] [Related]
3. Does the positive inotropic action of a novel cardiotonic agent, MCI-154, involve mechanisms other than cyclic AMP? Kitada Y; Narimatsu A; Suzuki R; Endoh M; Taira N J Pharmacol Exp Ther; 1987 Nov; 243(2):639-45. PubMed ID: 2824754 [TBL] [Abstract][Full Text] [Related]
4. Pharmacological characterization of effects of UK-1745, a novel cardiotonic agent with beta-adrenoceptor-blocking action, in aequorin-loaded canine right ventricular muscle. Sawada H; Endoh M J Mol Cell Cardiol; 1999 May; 31(5):1047-62. PubMed ID: 10336843 [TBL] [Abstract][Full Text] [Related]
5. Differential effects of sulmazole (AR-L 115 BS) on contractile force and cyclic AMP levels in canine ventricular muscle: comparison with MDL 17,043. Endoh M; Yanagisawa T; Morita T; Taira N J Pharmacol Exp Ther; 1985 Jul; 234(1):267-73. PubMed ID: 2989507 [TBL] [Abstract][Full Text] [Related]
6. Enhanced relaxation and reduced positive inotropic effects of amrinone in ventricular muscle from cats with subacute heart failure. Implications for drug therapy. Bassett AL; Gaide MS; Lodge NJ; Cameron JS Adv Myocardiol; 1985; 6():629-36. PubMed ID: 2986264 [TBL] [Abstract][Full Text] [Related]
7. Relationship between inhibition of cardiac muscle phosphodiesterases, changes in cyclic nucleotide levels, and contractile response for CI-914 and other novel cardiotonics. Weishaar RE; Quade MM; Schenden JA; Evans DB J Cyclic Nucleotide Protein Phosphor Res; 1985; 10(6):551-64. PubMed ID: 3003170 [TBL] [Abstract][Full Text] [Related]
8. The inotropic effects of amrinone and milrinone on neonatal and young canine cardiac muscle. Binah O; Sodowick B; Vulliemoz Y; Danilo P; Rosen M Circulation; 1986 Mar; 73(3 Pt 2):III46-51. PubMed ID: 3002663 [TBL] [Abstract][Full Text] [Related]
9. Involvement of cyclic AMP in the positive inotropic effect of OPC-8212, a new cardiotonic agent, on the canine ventricular muscle. Yanagisawa T; Endoh M; Taira N Jpn J Pharmacol; 1984 Nov; 36(3):379-88. PubMed ID: 6097725 [TBL] [Abstract][Full Text] [Related]
10. Effects of a new cardiotonic agent 1,2-dihydro-6-methyl-2-oxo-5-[imidazo (1,2-a) pyridin-6-yl]-3-pyridine carbonitrile hydrochloride monohydrate (E-1020) on contractile force and cyclic AMP metabolism in canine ventricular muscle. Satoh H; Endoh M Jpn J Pharmacol; 1990 Feb; 52(2):215-24. PubMed ID: 2156096 [TBL] [Abstract][Full Text] [Related]
11. Pharmacology of the bipyridines: amrinone and milrinone. Alousi AA; Johnson DC Circulation; 1986 Mar; 73(3 Pt 2):III10-24. PubMed ID: 2417744 [TBL] [Abstract][Full Text] [Related]
12. Effects of several newer cardiotonic drugs on cardiac cyclic AMP metabolism. Ahn HS; Eardley D; Watkins R; Prioli N Biochem Pharmacol; 1986 Apr; 35(7):1113-21. PubMed ID: 2421728 [TBL] [Abstract][Full Text] [Related]
13. Cyclic GMP-dependent protein kinase activation in the absence of negative inotropic effects in the rat ventricle. MacDonell KL; Diamond J Br J Pharmacol; 1997 Dec; 122(7):1425-35. PubMed ID: 9421291 [TBL] [Abstract][Full Text] [Related]
14. Chronotropic and inotropic actions of amrinone, carbazeran and isobutylmethyl xanthine: role of phosphodiesterase inhibition. Shahid M; Rodger IW Br J Pharmacol; 1989 Sep; 98(1):291-301. PubMed ID: 2478244 [TBL] [Abstract][Full Text] [Related]
15. Molecular basis for the cardiovascular activities of amrinone and AR-L57. Hayes JS; Bowling N; Boder GB; Kauffman R J Pharmacol Exp Ther; 1984 Jul; 230(1):124-32. PubMed ID: 6086873 [TBL] [Abstract][Full Text] [Related]
16. Different mechanisms involved in the positive inotropic effects of benzimidazole derivative UD-CG 115 BS (pimobendan) and its demethylated metabolite UD-CG 212 Cl in canine ventricular myocardium. Endoh M; Shibasaki T; Satoh H; Norota I; Ishihata A J Cardiovasc Pharmacol; 1991 Mar; 17(3):365-75. PubMed ID: 1711596 [TBL] [Abstract][Full Text] [Related]
17. Effects of a new 1,3-thiazole derivative ZSY-39 on force of contraction and cyclic AMP content in canine ventricular muscle. Endoh M; Satoh H; Norota I; Hirano K Cardiovasc Drugs Ther; 1990 Aug; 4(4):1127-34. PubMed ID: 1964579 [TBL] [Abstract][Full Text] [Related]
18. Adenosine inhibition of catecholamine-induced increase in force of contraction in guinea-pig atrial and ventricular heart preparations. Evidence against a cyclic AMP- and cyclic GMP-dependent effect. Böhm M; Brückner R; Hackbarth I; Haubitz B; Linhart R; Meyer W; Schmidt B; Schmitz W; Scholz H J Pharmacol Exp Ther; 1984 Aug; 230(2):483-92. PubMed ID: 6086891 [TBL] [Abstract][Full Text] [Related]
19. Proteolysis of cyclic AMP phosphodiesterase-II attenuates its ability to be inhibited by compounds which exert positive inotropic actions in cardiac tissue. Price B; Pyne NJ; Houslay MD Biochem Pharmacol; 1987 Dec; 36(23):4047-54. PubMed ID: 2825712 [TBL] [Abstract][Full Text] [Related]
20. Evidence for opposing influences of cyclic GMP and cyclic AMP on force of contraction in mammalian myocardium. Nawrath H Recent Adv Stud Cardiac Struct Metab; 1976 May 26-29; 11():419-22. PubMed ID: 201992 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]